BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16435054)

  • 1. Detection of F508del mutation in cystic fibrosis transmembrane conductance regulator gene mutation among Malays.
    Zilfalil BA; Sarina S; Liza-Sharmini AT; Oldfield NJ; Stenhouse SA
    Singapore Med J; 2006 Feb; 47(2):129-33. PubMed ID: 16435054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
    Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
    Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genotypes of cystic fibrosis (CF) reported in the world and polymorphisms of cystic fibrosis transmembrane conductance regulator (CFTR) gene in Japanese].
    Wang W; Okayama H; Shirato K
    Nihon Rinsho; 1996 Feb; 54(2):525-32. PubMed ID: 8838109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
    Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
    Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.
    Al-Abadi B; Al-Hiary M; Khasawneh R; Al-Momani A; Bani-Salameh A; Al-Saeidat S; Al-Khlaifat A; Aboalsondos O
    Med Arch; 2019 Apr; 73(2):118-120. PubMed ID: 31391700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a large heterozygous deletion and a splicing defect in the CFTR transcripts from nasal swab of a Japanese case of cystic fibrosis.
    Nakakuki M; Fujiki K; Yamamoto A; Ko SB; Yi L; Ishiguro M; Yamaguchi M; Kondo S; Maruyama S; Yanagimoto K; Naruse S; Ishiguro H
    J Hum Genet; 2012 Jul; 57(7):427-33. PubMed ID: 22572733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatments.
    Singh M; Rebordosa C; Bernholz J; Sharma N
    Respirology; 2015 Nov; 20(8):1172-81. PubMed ID: 26437683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p.F508del in a heterogeneous cystic fibrosis population from Minas Gerais, Brazil.
    Vidigal PV; Reis FJ; Boson WL; De Marco LA; Brasileiro-Filho G
    Braz J Med Biol Res; 2008 Aug; 41(8):643-7. PubMed ID: 18797695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.
    Furgeri DT; Marson FAL; Correia CAA; Ribeiro JD; Bertuzzo CS
    Gene; 2018 Jan; 641():137-143. PubMed ID: 29054758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Cystic Fibrosis Conductance Regulator Gene Mutations Reported in Pakistani Descent Cystic Fibrosis Patients.
    Majid H; Khan AH; Hashmi SB; Moatter T; Nasir A
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1042-1046. PubMed ID: 35932130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
    Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
    Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
    Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
    Arora K; Naren AP
    Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.